The Translational Psychedelics Research Program brings together scientists and providers to understand how psychedelics impact the brain and other organ systems
San Francisco, CA
Based in United States
- Tweets 149
- Following 105
- Followers 1,457
- Likes 37
Excited to announce a new milestone for TrPR. This week we successfully dosed three participants with psilocybin. Our capacity to deliver psychedelic therapy is increasing.
3
21
2,486
TrPR's @UCSF_AndrewPenn, a psychiatric nurse practitioner and #psychedelic psychotherapy researcher, discusses the key elements of psychedelic-assisted therapy on the latest episode of @psychmedpod. psychedelicmedicineassociati…
2
4
525
The clinical social worker will provide evidence-based psychotherapy under the research protocol. Under the supervision of senior clinical staff, they will provide psychotherapy, using evidence-based practices. They will also provide crisis intervention and emotional support.
1
3
TrPR is currently recruiting Cantonese/Mandarin speaking research assistants and facilitators! The primary function of this position is to provide psychotherapy services for the Translational Psychedelic Research Program.
3
8
(5/5) Learn the full requirements and specifications for this position by visiting tiny.ucsf.edu/1KNEk8.
2
(4/5)The position requires providing clinical coverage, performing physical examinations, taking medical and psychiatric histories, ordering labs, managing medication tapers, evaluating adverse events and lab reports, and providing on-call coverage during & after dosing sessions.
1
2
(3/5) The hourly commitment for this position ranges from 4-15 hours per week, depending on study activity, needs, and candidate’s availability/background.
1
1
(2/5) Our ideal candidate is an advanced practice registered nurse who possesses the advanced education, knowledge, clinical skills, and experience necessary to provide expert advanced nursing care in the area of psychiatric specialization.
1
3
(1/5) TrPR is currently seeking a part-time Nurse Practitioner II (NP II) to support several ongoing clinical trials of novel therapeutic interventions. These therapies target conditions such as Major Depressive Disorder.
2
3
8
(4/4) Check out this informative interview at TrPR’s blog, psychedelics.ucsf.edu/blog-0
1
2
(3/4) Among several other topics, Melinda and Gisele discuss ketamine and psilocybin in treating depression and anxiety, dosing preparation sessions, the client-centered approach, inclusion, and advice for aspiring psychedelic psychotherapists.
1
2
(1/4) Melinda Wang, a UCLA medical student here at TrPR, recently conducted an interview with Gisele Fernandes-Osterhold, a psychedelic facilitator! Gisele has extensive training and clinical experience in trauma-informed psychotherapy, using an integrative approach.
1
1
7
It's true! We have multiple positions and we are open to candidates with varied graduate backgrounds. Reach out if you are interested.
Interested in psychedelics? @TrPR_Program is hiring postdocs to work on psychedelic clinical trials for multiple conditions & first-in-human trials of novel compounds. We use multiple modalities including imaging, behavior, & blood-based biomarkers to explore mechanisms of action
2
3
12
But what is at stake, particularly when it comes to ketamine’s safety and efficacy together with other more traditional antidepressants? Learn about ketamine’s possible interactions with different classes of antidepressants by checking out the blog post at psychedelics.ucsf.edu/blog-0
7
TrPR has just published a new blog post, “Interactions between ketamine and prescription antidepressants”! As a party-drug-turned-“new-age”-antidepressant, ketamine has injected some pizzazz into the world of psychopharmacology.
1
2
10
But what does this all mean - down at the molecular level? How do psychedelics modulate our brain? Can science close the explanatory gap between the subjective experiences of psilocybin and our current objective understanding of its neuropharmacology?
2
5
Check out TrPR's blog post from last week, “What happens when we take psilocybin?” by Melinda Wang! Many may understand psilocybin, the core psychoactive component of “magic mushrooms”, as a compound that induces powerful and mind-bending hallucinations. psychedelics.ucsf.edu/blog/w…
1
2
4
If someone is considering engaging in psychedelic-assisted treatment for a psychiatric or psychological issue, it is imperative to discuss this with a trained medical professional before use. Check out this blog post at psychedelics.ucsf.edu/blog/m…!
1
3
Last week, TrPR published a new blog post, Medical Contraindications to “Classic” Psychedelic Use by Dr. Gowri Aragam! The post discusses contraindications – a reason someone should not receive treatment because of medical/psychological harm – as they relate to side effects.
1
1
8
Ultimately, the aim of this dynamic and integrative treatment is the long-term reduction of psychological distress and increase in the quality of daily life. Check out psychedelics.ucsf.edu/blog-0 to read this blog post and learn more about psychedelic-assisted psychotherapy!
1
3